Disease management
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.
BlueRock Therapeutics will utilize Rune Labs' StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson's disease.
The wearable device directly measures respiration to predict deterioration in COPD patients.
Viz.ai also announced an agreement with Bristol Myers Squibb to identify patients with hypertrophic cardiomyopathy.
Also, medical device unicorn Molbio has taken a 70% stake in digital x-ray manufacturer Prognosys.
The Copenhagen-based digital health company will work with Novartis to build digital health tools for chronic conditions where they see unmet needs and the potential for disease progression.
Spanish home care startup Senniors raised $5.6 million, and health benefits company Thatch launched with more than $6 million raised in pre-seed and seed funding.
The funds will be used to expand its research and development teams in the U.S. and Israel.
Data is collected via a sensor on a user's chin during sleep and analyzed using AI to aid in diagnosing sleep apnea or other sleep-related conditions.
The Omnipod maker purchased assets related to Bigfoot Biomedical's pump-based automated insulin delivery technology.